Read some of the latest prostate cancer NEWS You Can Use from Us TOO

Prostate Cancer News You Can Use from Us TOO provides some of the latest news articles on prostate cancer and is distributed via email each month at no charge.

Made possible by a charitable contribution from




Opt-In
to receive prostate cancer news articles from Us TOO


Findings on Prostate Cancer Detailed by Researchers at University of Illinois Urbana-Champaign (Dietary Tomato or Lycopene Do Not Reduce Castration-Resistant Prostate Cancer Progression in a Murine Model)

2020 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news originating from

Studies from Duke University School of Medicine Reveal New Findings on Prostate Cancer (Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer)

2020 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Daily -- Fresh data on Oncology - Prostate Cancer are presented in a new report. According to

VA Launches Clinical Trial for Veterans With COVID-19 Based on Prostate Cancer Drug

WASHINGTON, May 16 -- The U.S. Department of Veterans Affairs issued the following news release:The U.S. Department of Veterans Affairs (VA) began a new clinical trial to test a

Androgen-deprivation treatments for prostate cancer could protect men from COVID-19

2020 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at CDC & FDA Daily -- A study of 4532 men in the Veneto region of Italy has found that those who were being treated for

Myriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate Cancer

SALT LAKE CITY, May 20, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food

LYNPARZA® (Olaparib) Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP inhibitor to improve overall survival vs enzalutamide or abiraterone in the biomarker-based subset of prostate cancer patients with BRCA1/2 or ATM mutations Approximately

Decipher Prostate RP Identifies Prostate Cancer Patients Likely to Benefit from Hormonal Therapy

In a phase III, randomized controlled trial (RTOG 96-01), Decipher Prostate RP from Decipher Biosciences, San Diego, demonstrated the ability to accurately identify which prostate

Prolaris Predicts Which Prostate Cancer Patients Will Benefit from Multimodality Therapy

Prolaris, from Myriad Genetics, Salt Lake City, accurately predicts which men with intermediate- or high-risk prostate cancer will benefit from multimodality therapy and which can

New Findings from University of California Irvine in Prostate Cancer Provides New Insights (Testosterone replacement therapy reduces biochemical recurrence post-radical prostatectomy)

2020 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Disease Prevention Daily -- Current study results on Oncology - Prostate Cancer have been published. According to

Impact of metastatic prostate cancer on human bone marrow

2020 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily - According to news reporting based on a preprint abstract, our journalists obtained the

Dynamics of the cell-free DNA methylome of metastatic castration resistant prostate cancer during androgen-targeting treatment (Published April 9, 2020)

2020 APR 23 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- By a News Reporter-Staff News Editor at NewsRx Drug Daily - According to news reporting based

After prostate removal, where does PSA come from?

DEAR DR. ROACH: Some 20 years ago, as I was turning 50, a biopsy confirmed prostate cancer. I elected to deal with that through surgery, a radical perineal prostatectomy. For the

Former Congressman Mark Foley says his prostate cancer has returned

Former Congressman Mark Foley, who thought he had overcome prostate cancer in 2011, said Sunday the disease has returned. “In October, I was advised that the prostate cancer, that

PSA prostate screening stirs debateDebating the value of PSA prostate screening

We've long been schooled on the lifesaving value of early detection of a potentially deadly cancer. So when a simple blood test was introduced in 1994 that could detect the

Younger men with prostate cancer benefit from more aggressive treatment

For younger men diagnosed with prostate cancer, a "wait-and-see" approach is often recommended -- sometimes delaying treatment until the disease, and its symptoms, worsen. However

Recent Findings from Pfizer Provides New Insights into Veterans Health (Economic Outcomes In Patients With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate Plus Prednisone)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Defense & Aerospace Daily -- Fresh data on Veterans Health are presented in a new report. According to news

USA: Cunningham Introduces Bipartisan Bill to Help VA Tackle Prostate Cancer

Source: United States House of Representatives – Congressman Joe Cunningham (SC-1) March 5, 2020 Press Release Washington, D.C. – Today, Rep. Joe Cunningham (SC-01) and Rep. Neal

New Prostate Cancer Study Findings Have Been Reported by Researchers at University of Nebraska Medical Center (Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Daily News -- Current study results on Oncology - Prostate Cancer have been published. According to news

Investigators from University of Paris Sud Have Reported New Data on Prostate Cancer (Overall Survival In Men With Bone Metastases From Castration-resistant Prostate Cancer Treated With Bone-targeting Radioisotopes a Meta-analysis of Individual ...)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- A new study on Oncology - Prostate Cancer is now available. According to news reporting

Reports Outline Prostate Cancer Study Findings from Ontario Institute for Cancer Research (The Proteogenomic Landscape of Curable Prostate Cancer)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Daily -- Researchers detail new data in Oncology - Prostate Cancer. According to news reporting

New Prostate Cancer Findings from Johns Hopkins University School of Medicine Described (Incidental periprostatic schwannoma discovered during evaluation for prostatic adenocarcinoma)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Daily -- A new study on Oncology - Prostate Cancer is now available. According to news originating

Study Findings from University of Toronto Broaden Understanding of Prostate Cancer (Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer?)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Current study results on Oncology - Prostate Cancer have been published. According to news

Researchers from Royal College of Surgeons Report Details of New Studies and Findings in the Area of Prostate Cancer (Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate ...)

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Current study results on Oncology - Prostate Cancer have been published. According to news

New Prostate Cancer Study Findings Have Been Reported by Researchers at Carolina Urologic Research Center (A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer ...)

2020 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Chemicals & Chemistry Daily Daily -- Investigators discuss new findings in Oncology - Prostate Cancer. According to


Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.

Subscribe to the news feed and emails from Us TOO.

Click here to Subscribe

CLICK HERE and opt-in to receive free educational emails from Us TOO.